Lv3
288 积分 2020-04-03 加入
Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment‐Refractory Depression
1个月前
已完结
Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions
3个月前
已完结
Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients
7个月前
已完结
Population Pharmacokinetic-Pharmacodynamic Modeling of Haloperidol in Patients With Schizophrenia Using Positive and Negative Syndrome Rating Scale
7个月前
已完结
Population Pharmacokinetic/Pharmacodynamic Model of Clozapine for Characterizing the Relationship Between Accumulated Exposure and PANSS Scores in Patients With Schizophrenia
7个月前
已完结
Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants
7个月前
已关闭
Update Lessons from Positron Emission Tomography Imaging Part I: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antipsychotics
7个月前
已完结
An Integrated AI‐PBPK Platform for Predicting Drug In Vivo Fate and Tissue Distribution in Human and Inter‐Species Extrapolation
7个月前
已完结
Strategies and Recommendations for Using a Data‐Driven and Risk‐Based Approach in the Selection of First‐in‐Human Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment
8个月前
已完结
Estimating the starting dose for entry into humans: principles and practice
9个月前
已完结
皖公网安备34019202002308
